المؤلفون: AK Nooka, LJ Costa, CJ Gasparetto, PG Richardson, DS Siegel, A Chari, S Lentzsch, S Jagannath, J. Mikhael

المصدر: Clinical Lymphoma Myeloma and Leukemia. 22:e526-e531

مصطلحات موضوعية: Adult, Cancer Research, Consensus, Hydrazines, Oncology, Antineoplastic Combined Chemotherapy Protocols, Humans, Hematology, Triazoles, Multiple Myeloma, Dexamethasone

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0e4f154fc17c0bdb11485b4653167d7
https://doi.org/10.1016/j.clml.2022.01.014

المؤلفون: Ballas L; Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California. Electronic address: Leslie.Ballas@cshs.org., Ailawadhi S; Department of Hematology, Mayo Clinic, Jacksonville, Florida., Narang M; US Oncology Research, Maryland Oncology Hematology, Columbia, Maryland., Gasparetto CJ; Department of Medicine, Duke University Medical Center, Durham, North Carolina., Lee HC; The Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hardin JW; Department of Epidemiology and Biostatistics, University of South Carolina, Columbia, South Carolina., Durie BGM; Department of Hematology and Oncology, Cedars-Sinai Medical Center, Los Angeles, California., Toomey K; Department of Internal Medicine, Medical Oncology, and Hematology, Steeplechase Cancer Center, Somerville, New Jersy., Omel J; Myeloma Research Advocate/Advisor, Grand Island, Nebraska., Wagner LI; Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina., Abonour R; Department of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, Indiana., Terebelo HR; Department of Hematology, Internal Medicine, and Medical Oncology, Providence Cancer Institute, Southfield, Michigan., Joshi P; Bristol Myers Squibb, Princeton, New Jersey., Yu E; Bristol Myers Squibb, Princeton, New Jersey., Liu L; Bristol Myers Squibb, Princeton, New Jersey., Rifkin RM; Department of Medical Oncology/Hematology, Rocky Mountain Cancer Centers, US Oncology, Denver, Colorado., Jagannath S; Department of Hematology and Medical Oncology, Mount Sinai Hospital, New York, New York.

المصدر: Practical radiation oncology [Pract Radiat Oncol] 2024 Mar-Apr; Vol. 14 (2), pp. e141-e149. Date of Electronic Publication: 2023 Nov 19.

نوع المنشور: Observational Study; Multicenter Study; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101558279 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-8519 (Electronic) Linking ISSN: 18798500 NLM ISO Abbreviation: Pract Radiat Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/radiotherapy , Osteoporosis*, Adult ; Humans ; Prospective Studies ; Ethnicity ; Registries

المؤلفون: Nooka AK; Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, GA. Electronic address: anooka@emory.edu., Costa LJ; University of Alabama Blood and Marrow Transplantation Program, University of Alabama at Birmingham, Birmingham, AL., Gasparetto CJ; Duke University School of Medicine, Durham, NC., Richardson PG; Multiple Myeloma Program, Dana-Farber Cancer Institute, Boston, MA., Siegel DS; Division Chief, Multiple Myeloma, Hackensack Meridian Health, Hackensack, NJ., Chari A; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Lentzsch S; Division of Hematology and Oncology, Department of Medicine, Columbia University, New York, NY., Jagannath S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Mikhael J; Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute (TGen), City of Hope Cancer Center, Phoenix, AZ.

المصدر: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Jul; Vol. 22 (7), pp. e526-e531. Date of Electronic Publication: 2022 Feb 04.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/pathology, Adult ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Consensus ; Dexamethasone/pharmacology ; Dexamethasone/therapeutic use ; Humans ; Hydrazines/pharmacology ; Hydrazines/therapeutic use ; Triazoles

المؤلفون: Sung AD; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina. Electronic address: anthony.sung@duke.edu., Giri VK; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina; Stanford Department of Internal Medicine, Stanford, California., Tang H; Duke University School of Medicine, Durham, North Carolina., Nichols KR; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina., Lew MV; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina., Bohannon L; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina., Ren Y; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina., Jung SH; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina., Dalton T; Duke University School of Medicine, Durham, North Carolina., Bush A; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina., Van Opstal J; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina., Artica A; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina., Messina J; Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina., Shelby R; Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina., Frith J; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina., Lassiter M; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina; Clinical Nurse Specialist, Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Burleson J; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina., Leonard K; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina., Potter AS; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina., Choi T; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina., Gasparetto CJ; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina., Horwitz ME; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina., Long GD; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina., Lopez RD; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina., Sarantopoulos S; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina., Chao NJ; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.

المصدر: Transplantation and cellular therapy [Transplant Cell Ther] 2022 Apr; Vol. 28 (4), pp. 207.e1-207.e8. Date of Electronic Publication: 2022 Jan 20.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation* , Quality of Life*, Case-Control Studies ; Humans ; Recurrence ; Transplantation, Autologous ; United States

المؤلفون: Lee HC; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. hclee@mdanderson.com., Ailawadhi S; Mayo Clinic, Jacksonville, FL, USA., Gasparetto CJ; Duke University Medical Center, Durham, NC, USA., Jagannath S; Mount Sinai Hospital, New York, NY, USA., Rifkin RM; Rocky Mountain Cancer Centers US Oncology Research, Denver, CO, USA., Durie BGM; Cedars-Sinai Medical Center, Los Angeles, CA, USA., Narang M; Maryland Oncology Hematology, US Oncology Research, Columbia, MD, USA., Terebelo HR; Providence Cancer Institute, Southfield, MI, USA., Toomey K; The Steeplechase Cancer Center, Somerville, NJ, USA., Hardin JW; University of South Carolina, Columbia, SC, USA., Wagner L; Wake Forest School of Medicine, Winston-Salem, NC, USA., Omel JL; Myeloma Research Advocate/Advisor, Grand Island, NE, USA., Dhalla M; Bristol Myers Squibb, Princeton, NJ, USA., Liu L; Bristol Myers Squibb, Princeton, NJ, USA., Joshi P; Bristol Myers Squibb, Princeton, NJ, USA., Abonour R; Indiana University, Indianapolis, IN, USA.

مؤلفون مشاركون: Connect® MM Registry

المصدر: Blood cancer journal [Blood Cancer J] 2021 Jul 23; Vol. 11 (7), pp. 134. Date of Electronic Publication: 2021 Jul 23.

نوع المنشور: Clinical Trial; Letter; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma/*therapy, Age Factors ; Aged ; Aged, 80 and over ; Disease Management ; Female ; Humans ; Male ; Multiple Myeloma/diagnosis ; Multiple Myeloma/epidemiology ; Progression-Free Survival ; Registries ; Treatment Outcome

المؤلفون: Giri VK; Duke University School of Medicine, Durham, North Carolina; Stanford Department of Internal Medicine, Stanford, California. Electronic address: vgiri@stanford.edu., Kegerreis KG; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Ren Y; Duke Cancer Institute Biostatistics Shared Resources, Duke University Medical Center, Durham, North Carolina., Bohannon LM; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Lobaugh-Jin E; Department of Infection Prevention and Hospital Epidemiology, Duke University Medical Center, Durham, North Carolina., Messina JA; Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina., Matthews A; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Mowery YM; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina., Sito E; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Lassiter M; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Saullo JL; Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina., Jung SH; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina., Ma L; Department of Statistical Science, Duke University, Durham, North Carolina., Greenberg M; Department of Statistical Science, Duke University, Durham, North Carolina., Andermann TM; Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., van den Brink MRM; Department of Medicine and Department of Immunology, Weill Cornell Medical College, New York, New York; Adult Bone Marrow Transplantation service, Memorial Sloan Kettering Cancer Center, New York, New York., Peled JU; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York., Gomes ALC; Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York., Choi T; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Gasparetto CJ; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Horwitz ME; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Long GD; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Lopez RD; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Rizzieri DA; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Sarantopoulos S; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Chao NJ; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Allen DH; Duke University Health System Nursing, Durham, North Carolina., Sung AD; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina. Electronic address: anthony.sung@duke.edu.

المصدر: Transplantation and cellular therapy [Transplant Cell Ther] 2021 Mar; Vol. 27 (3), pp. 262.e1-262.e11. Date of Electronic Publication: 2021 Jan 07.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

مواضيع طبية MeSH: Cross Infection*/epidemiology , Hematopoietic Stem Cell Transplantation* , Sepsis*, Adult ; Chlorhexidine/analogs & derivatives ; Humans ; Incidence ; Inpatients ; Prospective Studies

المؤلفون: Ailawadhi S; Mayo Clinic, Jacksonville, Florida., Jagannath S; Mount Sinai Hospital, New York, New York., Lee HC; The University of Texas MD Anderson Cancer Center, Houston, Texas., Narang M; US Oncology Research, Columbia, Maryland., Rifkin RM; Rocky Mountain Cancer Centers, US Oncology Research, Denver, Colorado., Terebelo HR; Providence Cancer Institute, Southfield, Michigan., Durie BGM; Cedars-Sinai Medical Center, Los Angeles, California., Toomey K; Steeplechase Cancer Center, Somerville, New Jersey., Hardin JW; University of South Carolina, Columbia, South Carolina., Gasparetto CJ; Duke University Medical Center, Durham, North Carolina., Wagner L; Wake Forest School of Medicine, Winston-Salem, North Carolina., Omel JL; Myeloma Research Advocate/Advisor, Grand Island, Nebraska., He M; Bristol-Myers Squibb, Summit, New Jersey., Yue L; Bristol-Myers Squibb, Summit, New Jersey., Flick ED; Bristol-Myers Squibb, Summit, New Jersey., Agarwal A; Bristol-Myers Squibb, Summit, New Jersey., Abonour R; Indiana University, Indianapolis, Indiana.

مؤلفون مشاركون: Connect MM Registry Investigators

المصدر: Cancer [Cancer] 2020 Oct 01; Vol. 126 (19), pp. 4332-4340. Date of Electronic Publication: 2020 Jul 24.

نوع المنشور: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma/*ethnology , Multiple Myeloma/*mortality, Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Racial Groups ; Registries ; Survival Analysis ; United States ; Young Adult

المؤلفون: Jagannath S; Department of Hematology and Medical Oncology, Mount Sinai Hospital, New York, NY. Electronic address: sundar.jagannath@mountsinai.org., Rifkin RM; Department of Medical Oncology/Hematology, Rocky Mountain Cancer Centers US Oncology, Denver, CO., Gasparetto CJ; Department of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC., Toomey K; Department of Internal Medicine, Medical Oncology, and Hematology, Steeplechase Cancer Center, Somerville, NJ., Durie BGM; Department of Hematology/Oncology, Cedars-Sinai Medical Center, Los Angeles, CA., Hardin JW; Department of Epidemiology and Biostatistics, University of South Carolina, Columbia, SC., Terebelo HR; Department of Hematology, Internal Medicine, and Medical Oncology, Providence Cancer Institute, Southfield, MI., Wagner L; Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC., Narang M; Department of Medical Oncology/Hematology, US Oncology Research, Columbia, MD., Ailawadhi S; Department of Hematology, Mayo Clinic, Jacksonville, FL., Omel JL; Myeloma Research Advocate/Advisor, Grand Island, NE., Srinivasan S; Celgene Corporation, Summit, NJ., He M; Celgene Corporation, Summit, NJ., Ung B; Celgene Corporation, Summit, NJ., Kitali A; Celgene Corporation, Summit, NJ., Flick ED; Celgene Corporation, Summit, NJ., Agarwal A; Celgene Corporation, Summit, NJ., Abonour R; Department of Hematology/Oncology, Indiana University, Indianapolis, IN.

مؤلفون مشاركون: CONNECT MM Registry Investigators

المصدر: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2020 May; Vol. 20 (5), pp. 272-276. Date of Electronic Publication: 2019 Oct 14.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Video-Audio Media

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/diagnosis , Multiple Myeloma*/mortality , Multiple Myeloma*/therapy , Registries* , Stem Cell Transplantation*, Immunologic Factors/*administration & dosage , Proteasome Inhibitors/*administration & dosage, Aged ; Allografts ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Survival Rate

المؤلفون: Ailawadhi S; Mayo Clinic, Jacksonville, FL, USA., Jagannath S; Mount Sinai Hospital, New York, NY, USA., Narang M; US Oncology Research, Columbia, MD, USA., Rifkin RM; Rocky Mountain Cancer Centers US Oncology, Denver, CO, USA., Terebelo HR; Providence Cancer Institute, Southfield, MI, USA., Toomey K; Steeplechase Cancer Center, Somerville, NJ, USA., Durie BGM; Cedars-Sinai Medical Center, Los Angeles, CA, USA., Hardin JW; University of South Carolina, Columbia, SC, USA., Gasparetto CJ; Duke University Medical Center, Durham, NC, USA., Wagner L; Wake Forest School of Medicine, Winston-Salem, NC, USA., Omel JL; Myeloma Research Advocate/Advisor, Grand Island, NE, USA., Kumar V; Brigham and Women's Hospital, Boston, MA, USA., Yue L; Celgene Corporation, Summit, NJ, USA., Kitali A; Celgene Corporation, Summit, NJ, USA., Agarwal A; Celgene Corporation, Summit, NJ, USA., Abonour R; Indiana University, Indianapolis, IN, USA.

مؤلفون مشاركون: Connect MM Registry Investigators

المصدر: Cancer medicine [Cancer Med] 2020 Jan; Vol. 9 (1), pp. 35-42. Date of Electronic Publication: 2019 Nov 07.

نوع المنشور: Journal Article; Observational Study; Research Support, Non-U.S. Gov't; Validation Study

بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

مواضيع طبية MeSH: Databases, Factual/*statistics & numerical data , Multiple Myeloma/*mortality , Registries/*statistics & numerical data , SEER Program/*statistics & numerical data, Adult ; Aged ; Aged, 80 and over ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Proportional Hazards Models ; Puerto Rico/epidemiology ; Reproducibility of Results ; Survival Rate ; United States/epidemiology ; Young Adult

المؤلفون: Terebelo HR; Providence Cancer Institute, Southfield, MI, USA., Abonour R; Indiana University, Indianapolis, IN, USA., Gasparetto CJ; Duke University Medical Center, Durham, NC, USA., Toomey K; Steeplechase Cancer Center, Somerville, NJ, USA., Durie BGM; Cedars-Sinai Medical Center, Los Angeles, CA, USA., Hardin JW; University of South Carolina, Columbia, SC, USA., Jagannath S; Mount Sinai Hospital, New York, NY, USA., Wagner L; Wake Forest School of Medicine, Winston-Salem, NC, USA., Narang M; US Oncology Research, Columbia, MD, USA., Flick ED; Celgene Corporation, Summit, NJ, USA., Srinivasan S; Celgene Corporation, Summit, NJ, USA., Yue L; Celgene Corporation, Summit, NJ, USA., Kitali A; Celgene Corporation, Summit, NJ, USA., Agarwal A; Celgene Corporation, Summit, NJ, USA., Rifkin RM; Rocky Mountain Cancer Centers US Oncology, Denver, CO, USA.

مؤلفون مشاركون: CONNECT MM Registry Investigators

المصدر: British journal of haematology [Br J Haematol] 2019 Dec; Vol. 187 (5), pp. 602-614. Date of Electronic Publication: 2019 Aug 05.

نوع المنشور: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma/*diagnosis , Multiple Myeloma/*mortality, Adult ; Age Factors ; Aged ; Aged, 80 and over ; Chromosome Deletion ; Chromosomes, Human, Pair 17 ; Female ; Humans ; Male ; Middle Aged ; Multiple Myeloma/genetics ; Multiple Myeloma/pathology ; Neoplasm Staging ; Prognosis ; Proportional Hazards Models ; Registries ; Reproducibility of Results ; Risk Assessment/methods ; Smith-Magenis Syndrome/mortality ; Survival Analysis ; United States/epidemiology ; Young Adult

SCR Disease Name: Chromosome 17 deletion